Stay updated with breaking news from ரோனி ஸ்பைட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In-Person and Remote Detailing Data from AnswerSuite Indicates Hybrid Model is Here to Stay pressreleasepoint.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressreleasepoint.com Daily Mail and Mail on Sunday newspapers.
Syneos Health Acquires StudyKIK globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Syneos Health Names Michael Br - GuruFocus.com gurufocus.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gurufocus.com Daily Mail and Mail on Sunday newspapers.
Syneos Health Leaders Recognized For Visionary Healthcare Expertise Through HBA Healthcare Businesswomen’s Association Shines a Light on Lynn Hamilton and Katya Magonova May 06, 2021 07:30 ET | Source: Syneos Health, Inc. Syneos Health, Inc. MORRISVILLE, N.C., May 06, 2021 (GLOBE NEWSWIRE) Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Lynn Hamilton, Senior Director, Clinical Operations and Clinical Development Services, and Katya Magonova, MBA, Senior Engagement Manager, Commercial Advisory Group, have been recognized by the Healthcare Businesswomen’s Association (HBA) as exemplary female leaders in the biopharmaceutical industry for 2021. “While it was a tough decision to choose amongst a long list of women leaders across the organization, Lynn and Katya stood out. Both of these women are strong leaders, with exceptional talents, who con ....
Message : Required fields MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization, today announced it commenced an underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation (the “Selling Stockholders”) of an aggregate of 7,000,000 shares of the Company’s common stock (the “Offering”) pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission (“SEC”). The Selling Stockholders intend to grant the underwriter a 30-day option to purchase up to 1,050,000 additional shares of common stock. Syneos Health is not selling any shares and will not receive any proceeds from the sale of the shares by the Selling Stockholders in the Offering. ....